Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2011.01.008PMID 21376308PMCID PMC3061826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T helper17 cells are sufficient but not necessary to induce acute graft-versus-host disease.

  2010cited by this paper
• Cutting Edge: Negative Regulation of Dendritic Cells through Acetylation of the Nonhistone Protein STAT-31

  2009cited by this paper
• In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

  2009cited by this paper
• STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model

  2009cited by this paper
• IL-17 contributes to CD4-mediated graft-versus-host disease.

  2009cited by this paper
• Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice.

  2008cited by this paper
• STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease.

  2008cited by this paper
• Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

  2008cited by this paper
• Epithelial NEMO links innate immunity to chronic intestinal inflammation

  2007cited by this paper
• IFNgamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract.

  2007cited by this paper
• Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

  2007cited by this paper
• Transcriptional regulation of Th17 cell differentiation.

  2007cited by this paper
• Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1

  2007cited by this paper
• Differentiation and function of Th17 T cells.

  2007influential reference
• STAT3 Regulates Cytokine-mediated Generation of Inflammatory Helper T Cells*

  2007cited by this paper
• Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease

  2006influential reference
• Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras.

  2006cited by this paper
• The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

  2006cited by this paper
• NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages*

  2006cited by this paper
• STAT3-independent inhibition of lysophosphatidic acid-mediated upregulation of connective tissue growth factor (CTGF) by cucurbitacin I.

  2006cited by this paper
• NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.

  2006cited by this paper
• Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.

  2006cited by this paper
• Reduction of graft-versus-host disease by histone deacetylase inhibitor suberonylanilide hydroxamic acid is associated with modulation of inflammatory cytokine milieu and involves inhibition of STAT1.

  2006cited by this paper
• Review Articles (434 articles)

  2005cited by this paper
• Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity.

  2005cited by this paper
• In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.

  2005cited by this paper
• Kinetics of gene expression in murine cutaneous graft-versus-host disease.

  2004cited by this paper
• Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.

  2004cited by this paper
• Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

  2004cited by this paper
• Macrophage inflammatory protein 1-alpha (MIP-1 alpha ) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells.

  2003cited by this paper
• Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

  2003cited by this paper
• Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism1

  2003cited by this paper
• Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants.

  2002cited by this paper
• Cell type-specific and tyrosine phosphorylation-independent nuclear presence of STAT1 and STAT3.

  2002cited by this paper
• Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells.

  2002cited by this paper
• Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets.

  2000cited by this paper
• Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.

  2000cited by this paper
• How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene

  2000cited by this paper
• Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

  1998cited by this paper

• The Aberrantly Expressed Nuclear Factor (Erythroid-derived 2)-Like 2 Participates in aGVHD by Modulating the Activation and Differentiation of CD4+ T Lymphocytes

  2025cites this paper
• The Safety and Efficacy of Ruxolitinib in an Infant With Familial Hemophagocytic Syndrome Type 3: A Bridging Therapy Toward Hematopoietic Cell Transplantation and Treatment of Post‐Transplant Complications, Including Sinusoidal Obstruction Syndrome

  2025cites this paper
• Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation.

  2024cites this paper
• Treatment of Late-onset Acute Graft-versus-host Disease Following Double Lung Transplantation Using a JAK2 Inhibitor.

  2024cites this paper
• The Necroptosis Pathway Is Upregulated in the Cornea in Mice With Ocular Graft-Versus-Host Disease

  2024cites this paper
• Janus kinase inhibition in the treatment and prevention of graft-versus-host disease

  2024cites this paper
• Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis

  2024cites this paper
• Dissecting the regulatory network of transcription factors in T cell phenotype/functioning during GVHD and GVT

  2023cites this paper
• Phosphoflow cytometry to assess cytokine signaling pathways in peripheral immune cells: potential for inferring immune cell function and treatment response in patients with solid tumors

  2023cites this paper
• Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms.

  2023cites this paper
• IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

  2022cites this paper
• lnc‐AC145676.2.1‐6‐3 plays an important role in intestinal acute graft‐versus‐host disease through the regulation of interleukin‐1β

  2022cites this paper
• Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management.

  2022cites this paper
• T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?

  2022cites this paper
• Janus Kinase Inhibitors and Cell Therapy

  2021cites this paper
• Efficiency and Toxicity of Ruxolitinib as the Salvage Treatment in Steroid-Refractory Acute Graft-Versus-Host Disease after Haplo-Identical Stem Cell Transplantation.

  2021cites this paper
• Mechanisms of M2 Macrophage-Derived Exosomal Long Non-coding RNA PVT1 in Regulating Th17 Cell Response in Experimental Autoimmune Encephalomyelitisa

  2020cites this paper
• TIRC7 inhibits Th1 cells by upregulating the expression of CTLA-4 and STAT3 in mice with acute graft-versus-host disease

  2020cites this paper
• Advances in preclinical hematopoietic stem cell models and possible implications for improving therapeutic transplantation

  2020cites this paper
• Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD

  2020cites this paper
• Janus Kinase Inhibition for Graft-Versus-Host Disease: Current Status and Future Prospects

  2019cites this paper
• Graft Versus Host Disease (GHVD) in Critically Ill Oncologic Patients

  2018cites this paper
• Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH  trials.

  2018cites this paper
• Interferon regulatory factors: Where to stand in transplantation.

  2018cites this paper
• Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT

  2018cites this paper
• Chitinase 3‐like‐1 deficient donor splenocytes accentuated the pathogenesis of acute graft‐versus‐host diseases through regulating T cell expansion and type I inflammation

  2017cites this paper
• Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use

  2017cites this paper
• Identification of genes regulated in target organs of acute graft versus host disease in different organs in different species

  2016cites this paper
• Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide.

  2016cites this paper
• Cytotoxic T Lymphocyte Antigen-4 Down-Regulates T Helper 1 Cells by Increasing Expression of Signal Transducer and Activator of Transcription 3 in Acute Graft-versus-Host Disease.

  2016cites this paper
• Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies

  2016cites this paper
• Combined nifuroxazide and SAT05f therapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

  2016cites this paper
• IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition

  2015cites this paper
• MicroRNAs in haematopoietic stem cell transplantation outcome

  2015cites this paper
• MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation.

  2015cites this paper
• TRANSPLANTATION MicroRNA-155 – de fi cient dendritic cells cause less severe GVHD through reduced migration and defective in fl ammasome activation

  2015cites this paper
• Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation

  2015cites this paper
• The IL-33/ST2 axis augments effector T-cell responses during acute GVHD.

  2015cites this paper
• JAK1/STAT3 activation directly inhibits IL-12 production in dendritic cells by preventing CDK9/P-TEFb recruitment to the p35 promoter.

  2015cites this paper
• Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.

  2014cites this paper
• Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD.

  2014influential citation
• PIAS3 suppresses acute graft-versus-host disease by modulating effector T and B cell subsets through inhibition of STAT3 activation.

  2014cites this paper
• Bringing out the DCs' softer side in GVHD.

  2014cites this paper
• Helper T-Cell Differentiation in Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

  2014cites this paper
• Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?

  2013cites this paper
• Fibrosing connective tissue disorders of the skin: molecular similarities and distinctions.

  2013cites this paper
• Current data on IL-17 and Th17 cells and implications for graft versus host disease

  2013cites this paper
• The Role of Chemokines in Mediating Graft Versus Host Disease: Opportunities for Novel Therapeutics

  2011cites this paper
• Oral glutamine supplementation improves intestinal permeability dysfunction in a murine acute graft-vs.-host disease model.

  2011cites this paper